Concepedia

Dominique Lefrançois

DL

Statistics

Publications

3

Citations

137

H-Index

3

Active since

1995

Affiliations

Sanofi (France)(Current)

Dominique Lefrançois is an author at Sanofi (France) specializing in medicinal chemistry, pharmacology, and endothelin receptor signaling.

Publications per year

1995–2014

3

Publications

3

Discovery of (2<i>S</i>)-8-[(3<i>R</i>)-3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2<i>H</i>-pyrimido[1,2-<i>a</i>]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors

Benoit Pasquier, Youssef El‐Ahmad, Bruno Filoche-Rommé et al. · Journal of Medicinal Chemistry · 2014 · 92 citations

, , +13

Nonpeptide endothelin antagonists: from lower affinity pyrazol-5-ols to higher affinity pyrazole-5-carboxylic acids

Jidong Zhang, Stanislas Didierlaurent, Michel Fortin et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 24 citations · Full text

, , +10

An Expedient Synthesis of Ethyl 4(5)-Alkyl(aryl)thioimidazole-5(4)-carboxylate

Jean Claude Caille, Stanislas Didierlaurent, Dominique Lefrançois et al. · Synthesis · 1995 · 21 citations

, , +3

1–3 of 3